Epidermolyis bullosa acquisita (EBA) is a severe blistering disease of the skin characterized by separation of the epidermis from the dermis through the basement membrane zone (BMZ). Within the BMZ, immunoreactants are deposited immediately below the lamina densa, the site where blister formation begins. Using anti-BMZ auto-antibodies from EBA patients' sera, we identified the EBA antigen in human skin BMZ extracts by gel electrophoresis and Western immune blots as a large matrix macromolecule of 290,000 daltons that is distinct from bullous pemphigoid antigen, laminin, fibronectin, and collagen types I, IV and V. We now wish to purify and characterize the EBA antigen. O.4 mm keratotomed slices of skin will be de-epidermized in 1 M salt at 4 C for 96 hours, the epidermis discarded and the BMZ of the remaining dermis extracted in 8 M urea, 0.05 M Tris, pH 6.8 with reducing agents. Proteins below 100 kd will be removed by dialysis and ultrafiltration. Proteins above 100 kd will be separated by ion exchange chromatography, molecular sieve chromatography and hydroxylapatite chromatography. If further purification is needed, affinity chromatography with known matrix molecule affinity columns, anti-EBA monoclonal antibodies, commercially available affinity resins, and textile industrial dyes will be attempted. Isoelectric focusing will be done to obtain the isoelectric point of EBA antigen and as a preparative step. In addition to detecting EBA antigen by Coomasie blue stained gels and Western immune blots, and ELISA assay will be developed for rapid detections. Purified EBA antigen will be characterized by staphylococcal aureas V8 protease mapping, molecular sieve chromatography for a native molecular size, rotary shadowing for molecular shape, and biosynthetic labeling studies of cultures to determine its chemical classification. Biological properties including its cell binding ability (attachment assay), interactions with known matrix molecules (antigen-to-antigen ELISA), protease susceptibilities, and ability to provide a BMZ permiability barrier will be accessed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR033625-03
Application #
3156596
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1984-04-01
Project End
1987-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Guo, Jiacong; Jayaprakash, Priyamvada; Dan, Jian et al. (2017) PRAS40 Connects Microenvironmental Stress Signaling to Exosome-Mediated Secretion. Mol Cell Biol 37:
Zou, M; Bhatia, A; Dong, H et al. (2017) Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression. Oncogene 36:2160-2171
Dong, Hangming; Zou, Mengchen; Bhatia, Ayesha et al. (2016) Breast Cancer MDA-MB-231 Cells Use Secreted Heat Shock Protein-90alpha (Hsp90?) to Survive a Hostile Hypoxic Environment. Sci Rep 6:20605
Bhatia, Ayesha; O'Brien, Kathryn; Chen, Mei et al. (2016) Dual therapeutic functions of F-5 fragment in burn wounds: preventing wound progression and promoting wound healing in pigs. Mol Ther Methods Clin Dev 3:16041
Jayaprakash, Priyamvada; Dong, Hangming; Zou, Mengchen et al. (2015) Hsp90? and Hsp90? together operate a hypoxia and nutrient paucity stress-response mechanism during wound healing. J Cell Sci 128:1475-80
Hill, David S; Robinson, Neil D P; Caley, Matthew P et al. (2015) A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion. Mol Cancer Ther 14:2665-73
Woodley, David T; Cogan, Jon; Wang, Xinyi et al. (2014) De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 134:1138-1140
Cogan, Jon; Weinstein, Jacqueline; Wang, Xinyi et al. (2014) Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. Mol Ther 22:1741-52
O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred et al. (2014) Identification of the critical therapeutic entity in secreted Hsp90? that promotes wound healing in newly re-standardized healthy and diabetic pig models. PLoS One 9:e113956
Woodley, David T; Wang, Xinyi; Amir, Mahsa et al. (2013) Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol 133:1910-3

Showing the most recent 10 out of 82 publications